I thought it was funny when you wrote in a previous post "I have done more due diligence on this company then even the analyst at Aegis", especially when you now write "My understanding is that the final phase III trial has already been completed and that they are only waiting for the FDA's response. I believe these trials took place in the U.S. recently."
Do you understand that all clinical studies in the US as listed on the FDA clin trials dot gov site? Are any of AMPE's studies listed there? Hmmmmm.
Did you eve read AMPE's June 21 press release, which said "The FDA provided all the necessary guidance on the design and conduct of two concurrent phase III pivotal clinical trials of approximately 15 weeks duration."? Do you think AMPE just snuck those in?
Also, AMPE stated in the December investor presentation for Zertane "two concurrent
Phase III pivotal trials set to begin enrollment in 1Q13". Did you miss this?